Micrometastasis expressing insulin arise in lung and spleen at advanced stage of rip1-tag2 transgenic mice
- PMID: 24520211
- PMCID: PMC3920168
- DOI: 10.7150/ijbs.7515
Micrometastasis expressing insulin arise in lung and spleen at advanced stage of rip1-tag2 transgenic mice
Abstract
Rip1-Tag2 mice is one overt pancreatic β-cell tumor model, which is widely used for studying pancreas tumor angiogenesis and tumor development. However, tumor metastasis in Rip1-Tag2 mice had rarely been reported, in this present study, we find some micrometastasis in lung and spleen of the Rip1-Tag2 mice at advanced stage, which is important for uncovering metastasis cell characteristics and exploring how to survive in cancer microenvironment. To study the micrometastasis of Rip1-Tag2 mice in advanced pancreatic cancer, we first observed the pathology process of β cell tumor in Rip1-Tag2 mice through HE staining, then we performed immunohistochemistry with insulin antibody, T-antigen antibodies and C-petide antibody on lung and spleen tissues sections from advanced stage, comparing with background wild-type C57BL/6 mice sections. The results indicated that micrometastasis expressing insulin was found in the Rip1-Tag2 mice lung, and spleen. Further evidences demonstrate pathology structure of lung and spleen are damaged. Interestingly and importantly, the expression of T antigen and insulin antibodies are all decreased in advanced stage of primary β cell tumor, which suggest that the at least partly micrometastasis is derived from the early stage or from advanced stage of β cell tumor then return to undifferentiated state like cancer stem cell. The findings contributed to the study of cancer metastasis and cancer stem cell.
Keywords: Rip1-Tag2 transgenic mice; insulin; micrometastasis.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures
References
-
- Palmiter RD, Chen HY, Messing A, Brinster RL. SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice. Nature. 1985;316:457–60. - PubMed
-
- Park WY, Kim JI, Shim EH, Lee WH, Kim SH, Seo JW. et al. Development of thymic carcinoma in transgenic mice expressing SV40 T antigen. Cancer letters. 1996;107:293–300. - PubMed
-
- Butel JS, Sepulveda AR, Finegold MJ, Woo SL. SV40 large T antigen directed by regulatory elements of the human alpha-1-antitrypsin gene. A transgenic mouse system that exhibits stages in liver carcinogenesis. Intervirology. 1990;31:85–100. - PubMed
-
- Hanahan D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature. 1985;315:115–22. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
